Europe — EMA

Pamidronaatdinatrium Hospira (Pamidronate Disodium)

Pamidronate Disodium, the active ingredient in Pamidronaatdinatrium Hospira, is a bisphosphonate presented as a unknown/unknown for intravenous use.

Pamidronate Disodium

Request sourcing

Pack/s

What is Pamidronate Disodium?

Pamidronate Disodium, the active ingredient in Pamidronaatdinatrium Hospira, is a bisphosphonate presented as a unknown/unknown for intravenous use. It treats bone resorption disorders such as osteoporosis and hypercalcemia in adult patients. GNH USA supplies Pamidronaatdinatrium Hospira as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Pamidronaatdinatrium Hospira as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Pamidronate Disodium used for?

Pamidronate Disodium is a bisphosphonate that acts on bone metabolism pathways.

- Hypercalcemia of malignancy: reduces serum calcium levels. - Osteolytic bone metastases: helps prevent the progression of skeletal lesions. - Paget's disease of bone: normalises bone remodelling activity. - Osteoporosis (post‑menopausal): improves bone density and reduces fracture risk. - Bone pain associated with multiple myeloma and other malignancies : allev - ... ... ... ... - ... ... ...

What are the side effects of Pamidronate Disodium?

Common

What precautions apply to Pamidronate Disodium?

Precautions

What does Pamidronate Disodium interact with?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →